Antimicrobial resistance and extended spectrum beta-lactamases in urinary tract infections: A serious problem in Northern Mexico

Abstract Objective: To describe the causal agents, prevalence of antimicrobial resistance, and risk factors associated with extended spectrum beta-lactamase (ESBL)-producing agents in urinary tract infections (UTIs). Materials and methods: A retrospective study was conducted at a tertiary care hospital in Monterrey, Mexico. Inclusion criteria were patients that clinically presented with a UTI and had a positive urine culture, within the time frame of March to October 2017. The association with ESBL-producing agents was determined through the Χ2 test for categorical variables. Statistical significance was set at a p <0.05, utilizing SPSS version 20.0 software. Results: A total of 353 positive urine cultures were confirmed. ESBL production was found in 21.5% of the strains. There was a high level of resistance (>50%) to amoxicillin-clavulanate, ciprofloxacin, levofloxacin, fosfomycin, and trimethoprim-sulfamethoxazole and moderate resistance (10-50%) to gentamicin and ceftriaxone. Amikacin, ertapenem, nitrofurantoin, and colistin had the lowest resistance rates (<10%). The ESBL-producing agents were associated with complicated UTI (p≤0.0001). The comorbidities associated with ESBL-positive UTIs were diabetes mellitus (p=0.02) and immunodeficiency (p=0.008), as was having undergone radiotherapy (p=0.025) and previous antibiotic use (p≤0.001). Limitations: The clonal relationship of isolates, especially of E. coli, was not analyzed. We could not establish whether there was a high level of genetic diversity between the isolates or whether independent acquisition or cross-transmission occurred. Value: We evaluated the epidemiologic characteristics of the ESBL-producing agents in UTIs at a Mexican tertiary care hospital. Conclusions: One out of every five UTIs was caused by ESBLs in our study population. There was a high level of resistance to the antibiotics used as first-line empiric therapy in the patients studied.

Saved in:
Bibliographic Details
Main Authors: Robles-Torres,José Iván, Ocaña-Munguía,Marco Alberto, Madero Morales,Pedro Antonio, Ruiz-Galindo,Efraín, Garza-González,Elvira, Gómez-Guerra,Lauro
Format: Digital revista
Language:English
Published: Sociedad Mexicana de Urología 2020
Online Access:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2007-40852020000200002
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2007-40852020000200002
record_format ojs
spelling oai:scielo:S2007-408520200002000022022-01-17Antimicrobial resistance and extended spectrum beta-lactamases in urinary tract infections: A serious problem in Northern MexicoRobles-Torres,José IvánOcaña-Munguía,Marco AlbertoMadero Morales,Pedro AntonioRuiz-Galindo,EfraínGarza-González,ElviraGómez-Guerra,Lauro Extended spectrum beta-lactamase Urinary tract infections Drug resistance Urine culture Abstract Objective: To describe the causal agents, prevalence of antimicrobial resistance, and risk factors associated with extended spectrum beta-lactamase (ESBL)-producing agents in urinary tract infections (UTIs). Materials and methods: A retrospective study was conducted at a tertiary care hospital in Monterrey, Mexico. Inclusion criteria were patients that clinically presented with a UTI and had a positive urine culture, within the time frame of March to October 2017. The association with ESBL-producing agents was determined through the Χ2 test for categorical variables. Statistical significance was set at a p <0.05, utilizing SPSS version 20.0 software. Results: A total of 353 positive urine cultures were confirmed. ESBL production was found in 21.5% of the strains. There was a high level of resistance (>50%) to amoxicillin-clavulanate, ciprofloxacin, levofloxacin, fosfomycin, and trimethoprim-sulfamethoxazole and moderate resistance (10-50%) to gentamicin and ceftriaxone. Amikacin, ertapenem, nitrofurantoin, and colistin had the lowest resistance rates (<10%). The ESBL-producing agents were associated with complicated UTI (p≤0.0001). The comorbidities associated with ESBL-positive UTIs were diabetes mellitus (p=0.02) and immunodeficiency (p=0.008), as was having undergone radiotherapy (p=0.025) and previous antibiotic use (p≤0.001). Limitations: The clonal relationship of isolates, especially of E. coli, was not analyzed. We could not establish whether there was a high level of genetic diversity between the isolates or whether independent acquisition or cross-transmission occurred. Value: We evaluated the epidemiologic characteristics of the ESBL-producing agents in UTIs at a Mexican tertiary care hospital. Conclusions: One out of every five UTIs was caused by ESBLs in our study population. There was a high level of resistance to the antibiotics used as first-line empiric therapy in the patients studied.info:eu-repo/semantics/openAccessSociedad Mexicana de UrologíaRevista mexicana de urología v.80 n.2 20202020-04-01info:eu-repo/semantics/articletext/htmlhttp://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2007-40852020000200002en10.48193/rmu.v80i2.619
institution SCIELO
collection OJS
country México
countrycode MX
component Revista
access En linea
databasecode rev-scielo-mx
tag revista
region America del Norte
libraryname SciELO
language English
format Digital
author Robles-Torres,José Iván
Ocaña-Munguía,Marco Alberto
Madero Morales,Pedro Antonio
Ruiz-Galindo,Efraín
Garza-González,Elvira
Gómez-Guerra,Lauro
spellingShingle Robles-Torres,José Iván
Ocaña-Munguía,Marco Alberto
Madero Morales,Pedro Antonio
Ruiz-Galindo,Efraín
Garza-González,Elvira
Gómez-Guerra,Lauro
Antimicrobial resistance and extended spectrum beta-lactamases in urinary tract infections: A serious problem in Northern Mexico
author_facet Robles-Torres,José Iván
Ocaña-Munguía,Marco Alberto
Madero Morales,Pedro Antonio
Ruiz-Galindo,Efraín
Garza-González,Elvira
Gómez-Guerra,Lauro
author_sort Robles-Torres,José Iván
title Antimicrobial resistance and extended spectrum beta-lactamases in urinary tract infections: A serious problem in Northern Mexico
title_short Antimicrobial resistance and extended spectrum beta-lactamases in urinary tract infections: A serious problem in Northern Mexico
title_full Antimicrobial resistance and extended spectrum beta-lactamases in urinary tract infections: A serious problem in Northern Mexico
title_fullStr Antimicrobial resistance and extended spectrum beta-lactamases in urinary tract infections: A serious problem in Northern Mexico
title_full_unstemmed Antimicrobial resistance and extended spectrum beta-lactamases in urinary tract infections: A serious problem in Northern Mexico
title_sort antimicrobial resistance and extended spectrum beta-lactamases in urinary tract infections: a serious problem in northern mexico
description Abstract Objective: To describe the causal agents, prevalence of antimicrobial resistance, and risk factors associated with extended spectrum beta-lactamase (ESBL)-producing agents in urinary tract infections (UTIs). Materials and methods: A retrospective study was conducted at a tertiary care hospital in Monterrey, Mexico. Inclusion criteria were patients that clinically presented with a UTI and had a positive urine culture, within the time frame of March to October 2017. The association with ESBL-producing agents was determined through the Χ2 test for categorical variables. Statistical significance was set at a p <0.05, utilizing SPSS version 20.0 software. Results: A total of 353 positive urine cultures were confirmed. ESBL production was found in 21.5% of the strains. There was a high level of resistance (>50%) to amoxicillin-clavulanate, ciprofloxacin, levofloxacin, fosfomycin, and trimethoprim-sulfamethoxazole and moderate resistance (10-50%) to gentamicin and ceftriaxone. Amikacin, ertapenem, nitrofurantoin, and colistin had the lowest resistance rates (<10%). The ESBL-producing agents were associated with complicated UTI (p≤0.0001). The comorbidities associated with ESBL-positive UTIs were diabetes mellitus (p=0.02) and immunodeficiency (p=0.008), as was having undergone radiotherapy (p=0.025) and previous antibiotic use (p≤0.001). Limitations: The clonal relationship of isolates, especially of E. coli, was not analyzed. We could not establish whether there was a high level of genetic diversity between the isolates or whether independent acquisition or cross-transmission occurred. Value: We evaluated the epidemiologic characteristics of the ESBL-producing agents in UTIs at a Mexican tertiary care hospital. Conclusions: One out of every five UTIs was caused by ESBLs in our study population. There was a high level of resistance to the antibiotics used as first-line empiric therapy in the patients studied.
publisher Sociedad Mexicana de Urología
publishDate 2020
url http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2007-40852020000200002
work_keys_str_mv AT roblestorresjoseivan antimicrobialresistanceandextendedspectrumbetalactamasesinurinarytractinfectionsaseriousprobleminnorthernmexico
AT ocanamunguiamarcoalberto antimicrobialresistanceandextendedspectrumbetalactamasesinurinarytractinfectionsaseriousprobleminnorthernmexico
AT maderomoralespedroantonio antimicrobialresistanceandextendedspectrumbetalactamasesinurinarytractinfectionsaseriousprobleminnorthernmexico
AT ruizgalindoefrain antimicrobialresistanceandextendedspectrumbetalactamasesinurinarytractinfectionsaseriousprobleminnorthernmexico
AT garzagonzalezelvira antimicrobialresistanceandextendedspectrumbetalactamasesinurinarytractinfectionsaseriousprobleminnorthernmexico
AT gomezguerralauro antimicrobialresistanceandextendedspectrumbetalactamasesinurinarytractinfectionsaseriousprobleminnorthernmexico
_version_ 1756230637564461056